These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17661910)

  • 1. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis.
    Spagnolo P; Sato H; Grutters JC; Renzoni EA; Marshall SE; Ruven HJ; Wells AU; Tzouvelekis A; van Moorsel CH; van den Bosch JM; du Bois RM; Welsh KI
    Tissue Antigens; 2007 Sep; 70(3):219-27. PubMed ID: 17661910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles.
    Suzuki H; Ota M; Meguro A; Katsuyama Y; Kawagoe T; Ishihara M; Asukata Y; Takeuchi M; Ito N; Shibuya E; Nomura E; Uemoto R; Nishide T; Namba K; Kitaichi N; Morimoto S; Kaburaki T; Ando Y; Takenaka S; Nakamura J; Saeki K; Ohno S; Inoko H; Mizuki N
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7109-15. PubMed ID: 22991420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis.
    Morais A; Lima B; Peixoto MJ; Alves H; Marques A; Delgado L
    Respir Med; 2012 Dec; 106(12):1771-7. PubMed ID: 23017494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502.
    Mochida A; Kinouchi Y; Negoro K; Takahashi S; Takagi S; Nomura E; Kakuta Y; Tosa M; Shimosegawa T
    Tissue Antigens; 2007 Aug; 70(2):128-35. PubMed ID: 17610417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74.
    Simmonds MJ; Heward JM; Barrett JC; Franklyn JA; Gough SC
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):429-32. PubMed ID: 16984233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren's syndrome.
    Spagnolo P; Sato H; Grunewald J; Brynedal B; Hillert J; Mañá J; Wells AU; Eklund A; Welsh KI; du Bois RM
    J Intern Med; 2008 Nov; 264(5):433-41. PubMed ID: 18513341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations.
    Wolin A; Lahtela EL; Anttila V; Petrek M; Grunewald J; van Moorsel CHM; Eklund A; Grutters JC; Kolek V; Mrazek F; Kishore A; Padyukov L; Pietinalho A; Ronninger M; Seppänen M; Selroos O; Lokki ML
    Front Immunol; 2017; 8():422. PubMed ID: 28469621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15.
    Traherne JA; Barcellos LF; Sawcer SJ; Compston A; Ramsay PP; Hauser SL; Oksenberg JR; Trowsdale J
    Hum Mol Genet; 2006 Jan; 15(1):155-61. PubMed ID: 16321988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between sarcoidosis clinical course and ANXA11 rs1049550 C/T, BTNL2 rs2076530 G/A, and HLA class I and II alleles.
    Morais A; Lima B; Alves H; Melo N; Mota PC; Marques A; Delgado L
    Clin Respir J; 2018 Feb; 12(2):532-537. PubMed ID: 27662826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcoidosis is associated with a truncating splice site mutation in BTNL2.
    Valentonyte R; Hampe J; Huse K; Rosenstiel P; Albrecht M; Stenzel A; Nagy M; Gaede KI; Franke A; Haesler R; Koch A; Lengauer T; Seegert D; Reiling N; Ehlers S; Schwinger E; Platzer M; Krawczak M; Müller-Quernheim J; Schürmann M; Schreiber S
    Nat Genet; 2005 Apr; 37(4):357-64. PubMed ID: 15735647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression?
    Wijnen PA; Voorter CE; Nelemans PJ; Verschakelen JA; Bekers O; Drent M
    Hum Immunol; 2011 Apr; 72(4):342-7. PubMed ID: 21256912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites.
    Rybicki BA; Walewski JL; Maliarik MJ; Kian H; Iannuzzi MC;
    Am J Hum Genet; 2005 Sep; 77(3):491-9. PubMed ID: 16080124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome.
    Spagnolo P; Renzoni EA; Wells AU; Sato H; Grutters JC; Sestini P; Abdallah A; Gramiccioni E; Ruven HJ; du Bois RM; Welsh KI
    Am J Respir Crit Care Med; 2003 Nov; 168(10):1162-6. PubMed ID: 12882757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.
    Mrazek F; Holla LI; Hutyrova B; Znojil V; Vasku A; Kolek V; Welsh KI; Vacha J; du Bois RM; Petrek M
    Tissue Antigens; 2005 Feb; 65(2):163-71. PubMed ID: 15713215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a genetic predisposition for Turkish patients with sarcoidosis in the 329-bp region containing the BTNL2 rs2076530 polymorphism?
    Ozdemir M; Saydam F; Kurt E; Değirmenci I; Tuncel T; Cilingir O; Güneş HV; Artan S
    Turk J Med Sci; 2014; 44(4):590-4. PubMed ID: 25551927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTNL2 gene polymorphism and sarcoidosis susceptibility: a meta-analysis.
    Lin Y; Wei J; Fan L; Cheng D
    PLoS One; 2015; 10(4):e0122639. PubMed ID: 25849037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of the novel association at the BTNL2 locus with ulcerative colitis.
    Pathan S; Gowdy RE; Cooney R; Beckly JB; Hancock L; Guo C; Barrett JC; Morris A; Jewell DP
    Tissue Antigens; 2009 Oct; 74(4):322-9. PubMed ID: 19659809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2.
    Mitsunaga S; Hosomichi K; Okudaira Y; Nakaoka H; Kunii N; Suzuki Y; Kuwana M; Sato S; Kaneko Y; Homma Y; Kashiwase K; Azuma F; Kulski JK; Inoue I; Inoko H
    J Hum Genet; 2013 Apr; 58(4):210-5. PubMed ID: 23364395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 6p21.3 Risk Haplotype Predisposes to Acute Coronary Syndrome.
    Sinisalo J; Vlachopoulou E; Marchesani M; Nokelainen J; Mäyränpää MI; Lappalainen J; Paakkanen R; Wennerström A; Salli K; Niemi HJ; Männistö S; Salo P; Junttila J; Eskola M; Nikus K; Arstila TP; Perola M; Huikuri H; Karhunen PJ; Kovanen PT; Palotie A; Havulinna AS; Lluis-Ganella C; Marrugat J; Elosua R; Salomaa V; Nieminen MS; Lokki ML
    Circ Cardiovasc Genet; 2016 Feb; 9(1):55-63. PubMed ID: 26679868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
    Sato H; Spagnolo P; Silveira L; Welsh KI; du Bois RM; Newman LS; Maier LA
    Tissue Antigens; 2007 Dec; 70(6):480-6. PubMed ID: 17927685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.